PAPER Wei W, Sun H, Yang B, Zhu C, Song E, Song Y
SEARCH RESULTS
329963 RESULTS
PAPER Gilboa T, Swank Z, Thakur R, Gould RA, Ooi KH, Norman M, Flynn EA, Deveney BT, Chen A, Borberg E, Kuzkina A, Ndayisaba A, Khurana V, Weitz DA, Walt DR
Toward the quantification of α-synuclein aggregates with digital seed amplification assays.
Proc Natl Acad Sci U S A. 2024 Jan 16;121(3):e2312031121. Epub 2024 Jan 9 PubMed: 38194461PAPER Han SW, Pyun JM, Bice PJ, Bennett DA, Saykin AJ, Kim SY, Park YH, Nho K
miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease.
Alzheimers Res Ther. 2024 Jan 9;16(1):5. PubMed: 38195609PAPER Son G, Neylan TC, Grinberg LT
Neuronal and glial vulnerability of the suprachiasmatic nucleus in tauopathies: evidence from human studies and animal models.
Mol Neurodegener. 2024 Jan 10;19(1):4. PubMed: 38195580PAPER Zhang T, Kim BM, Lee TH
Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease.
Transl Neurodegener. 2024 Jan 9;13(1):4. PubMed: 38195518PAPER Athanasio BS, Oliveira AC, Pedrosa AL, Borges RS, Neto AO, Oliveira RA, de Resende EP, de Moraes RF, Caramelli P, de Souza LC
The role of brain perfusion SPECT in the diagnosis of frontotemporal dementia: A systematic review.
J Neuroimaging. 2024 Jan 8; PubMed: 38192155PAPER Tijms BM, Vromen EM, Mjaavatten O, Holstege H, Reus LM, van der Lee S, Wesenhagen KE, Lorenzini L, Vermunt L, Venkatraghavan V, Tesi N, Tomassen J, den Braber A, Goossens J, Vanmechelen E, Barkhof F, Pijnenburg YA, van der Flier WM, Teunissen CE, Berven FS, Visser PJ
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles.
Nat Aging. 2024 Jan;4(1):33-47. Epub 2024 Jan 9 PubMed: 38195725PAPER Tsuji K, Nakayama Y, Taruya J, Ito H
Persistence of Kii amyotrophic lateral sclerosis after the 2000s and its characteristic aging-related tau astrogliopathy.
J Neuropathol Exp Neurol. 2024 Jan 19;83(2):79-93. PubMed: 38193356PAPER Savva L, Platts JA
Computational investigation of copper-mediated conformational changes in α-synuclein dimer.
Phys Chem Chem Phys. 2024 Jan 24;26(4):2926-2935. PubMed: 38193190PAPER Hernandez-Candia CN, Brady BR, Harrison E, Tucker CL
A platform to induce and mature biomolecular condensates using chemicals and light.
Nat Chem Biol. 2024 Jan 8; PubMed: 38191942PAPER Gordón Pidal JM, Moreno-Guzmán M, Montero-Calle A, Valverde A, Pingarrón JM, Campuzano S, Calero M, Barderas R, López MÁ, Escarpa A
Micromotor-based electrochemical immunoassays for reliable determination of amyloid-β (1-42) in Alzheimer's diagnosed clinical samples.
Biosens Bioelectron. 2024 Apr 1;249:115988. Epub 2023 Dec 31 PubMed: 38194814PAPER Illes-Toth E, Rempel DL, Gross ML
Exploration of Resveratrol as a Potent Modulator of α-Synuclein Fibril Formation.
ACS Chem Neurosci. 2024 Feb 7;15(3):503-516. Epub 2024 Jan 9 PubMed: 38194353PAPER Kaleta M, Hényková E, Menšíková K, Friedecký D, Kvasnička A, Klíčová K, Koníčková D, Strnad M, Kaňovský P, Novák O
Patients with Neurodegenerative Proteinopathies Exhibit Altered Tryptophan Metabolism in the Serum and Cerebrospinal Fluid.
ACS Chem Neurosci. 2024 Feb 7;15(3):582-592. Epub 2024 Jan 9 PubMed: 38194490PAPER Qiang Q, Skudder-Hill L, Toyota T, Huang Z, Wei W, Adachi H, Alzheimer's Disease Neuroimaging Initiative
CSF 14-3-3 zeta(ζ) isoform is associated with tau pathology and cognitive decline in Alzheimer's disease.
J Neurol Sci. 2024 Feb 15;457:122861. Epub 2024 Jan 1 PubMed: 38194803PAPER Beveridge J, Kaniecki E, Naidu A, Silverglate BD, Grossberg G
How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer's disease?
Expert Opin Emerg Drugs. 2024 Mar;29(1):35-43. Epub 2024 Jan 12 PubMed: 38193477Current Filters
No filters selected